±±Ê¦´óϸ°ûÉúÎïѧ£º HsY5
wC
Ò»¡¢ Ãû´Ê½âÊÍ£º &:&'70Ya
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© fzsy<Vl",
2£® PCR£¨96£© >eJ<-3L;
3£® ·ºËØ£¨ubquitin£©£¨96£© \!u<)kkyT
4£® °é·Ö×Ó£¨chapron£©£¨96£© =LW!$p
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© 0ho;L 0Nr'
6£® DG£IP3£¨96£© JT+c7W7
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© dGKo!;7{
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© \&"C
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© EPm~@8@"j?
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© uwwR$
(\7
11£® Transformation£¨92£© qO6M5g:
12£® TransfectionתȾ£¨92£© nrac)W
13£® Transcytosis×ªÒÆ×÷Óã¨92£© ~\":o:qyc
14£® Transductionתµ¼£¨92£© yRXML\Ge
15£® Transdetermination£¨92£© O(^h_
16£® Transdifferentiation£¨92£© =p5DT
17£® Transgenic animalת»ùÒò¶¯Î92£© F#Lo
^ 8
18£® Rb£1£¨92£© E&U_1D9=L<
19£® P53£¨92¡¢91£© HTQZIm
20£® C£jun£¨92£© !XPjRd q
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© 4@9Pd &I
22£® °ûÄÚÌ壨99£© _ *f>UW*,
23£® Cyclin dependent kinase inhibitor(CDKI)(99) =AIts[!qd
24£® G£protein£¨91£© "U\RN
25£® Restriction point£¨91£© )/RG-L
26£® Antipost£¨91£© -^_2{i
27£® Capping£¨91£© 5B=uvp|Y
28£® TATAbox£¨91£© m8sd2&4
29£® cDNA library£¨90£© Q'OtXs 80
30£® Aritotic apparatus£¨90£© ~I||"$R
31£® ¿çĤÐźŠtransmembrane signal£¨90£© #Y7jNrxE
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© 7FC!^)x1
33£® Nuclear lamina£¨90£© P$EiD+5#z
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© YBt=8`r
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© s~M$Wo8
36£® ϸ°û·Ö»¯£¨00£© gFR}WBl/
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© ]8A*uyi
38£® ¿Ë¡£¨00£© E'x"EN
39£® »ùÒò×飨00£© h>pu^ `hk
40£® Caspase£¨00£© Ema[M5$R
41£® ת¼Òò×Ó£¨00£© {4g';
42£® ÅßÌ¥¸Éϸ°û£¨01£© y3~`qq
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© O#)1zD}
44£® DNAоƬ£¨01£© {$8+n::
¶þ¡¢ ÎÊ´ðÌ⣺
od=hCQ1>
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© HV a9b;
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© o GuAF q
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© ~4fE`-O
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© u@Hz7Q}
P
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© ;@Zuet
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© \Oq2{Sx\
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© =Kj{wA
O
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© Ph^1Ko"2
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© O#D{:H_dD>
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© }u8(7
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© DO~
D?/ia
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© "^&H9